50242-0177 Lunsumio Velo - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50242-0177

Brand Name:

Lunsumio Velo

Generic Name:

Mosunetuzumab

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: MOSUNETUZUMAB

Strength: 5.0

Unit: mg/.5mL

Packages:

Code: 50242-0177-01

Description: 1 VIAL, GLASS in 1 CARTON (50242-177-01) / .5 mL in 1 VIAL, GLASS

Effective Date: Dec. 19, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

CD20, CD3

Orphan Drug Designation:

Yes

Status:

In Use